| Intrinsic Valuation of: GEN | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 1 | Market Cap | $18B | |||||
| 2021 | - | - (-) | P/E Ratio | 28 | Total Asset | $15B | |||||
| 2022 | $968M | - (-) | Net Income | $643M | Total Debt | $8B | |||||
| 2023 | $751M | -22.4% (-34.6%) | EBITDA | $2B | Total Liab | $13B | |||||
| 2024 | $2B | 172.2% (137.6%) | Opr Margin | 0.41 | Debt/Equity | 3.51 | |||||
| 2025 | $1B | -41.0% (-43.0%) | PreTax Margin | 26.48 | BV/Share | -17 | |||||
| 5Y Average FCF | $1B | 36.3% (20.0%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | $2B | MBG Intrinsic Value | $9 | ||||||||
| 2027 | $2B | ||||||||||
| 2028 | $2B | ||||||||||
| 2029 | $3B | ||||||||||
| 2030 | $4B | ||||||||||
| 2031 | $5B | ||||||||||
| Terminal Value | $96B | Net Worth/Share | $4 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $75B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $1B | $110 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $8B | WACC | 7.3% | 94 | 102 | 112 | 125 | 140 | |||
| Equity Value | $68B | 7.4% | 93 | 101 | 111 | 123 | 138 | ||||
| Shares Outstanding | 620,230,016 | 7.4% | 92 | 100 | 110 | 121 | 136 | ||||
| 7.9% | 83 | 90 | 97 | 107 | 119 | ||||||
| DCF Intrinsic Value | $110 | 8.4% | 75 | 81 | 87 | 95 | 104 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||